Autism Impact Fund is the investment and innovation arm of the autism community.

Meet our portfolio companies >>

Cision PRWeb / April 20, 2022

Autism Impact Fund Makes Strategic
Investment in Cortica

NYSE / April 19, 2022

Autism Impact Fund Rings Closing Bell at
New York Stock Exchange

Latest news

Seed, 2021

diagnosis is achievable with
a simple blood test.

AIF is building a world where autism

September, 2021

SpectrumAI

behavioral intervention is clinically validated and data-driven.

Series C, 2021

therapeutics exist to address
core symptoms.

Seed, 2021

care is accessible.

Series A, 2021

treatments are safe, effective, and well-tolerated.

Seed, 2021

therapy is tech-enabled.

Bridge, 2021

is manageable with precise
nutrition.

Growth, 2021

employment opportunities
are plentiful.

Strategic, 2022

care is comprehensive,
outcomes-based,
and led by doctors.

Autism Impact Fund is the investment and innovation arm of the autism community.

Meet our portfolio companies >>

Cision PRWeb / April 20, 2022

AIF makes strategic investment in Cortica...

NYSE / April 19, 2022

AIF rings closing bell at NYSE...

Latest news

Seed, 2021

diagnosis is achievable with a simple blood test.

Austim Impact Fund is building a world where autism

September, 2021

behavioral intervention is clinically validated and data-driven.

SpectrumAI

Austim Impact Fund is building a world where autism

Series C, 2021

therapeutics exist to address core symptoms.

Seed, 2021

care is accessible.

Series A, 2021

treatments are safe, effective, and well-tolerated.

Seed, 2021

therapy is tech-enabled.

Bridge, 2021

is manageable with precise nutrition.

Growth, 2021

employment opportunities are plentiful.

Strategic, 2022

care is comprehensive,
outcomes-based,
and led by doctors.

Autism Impact Fund: Autism Research & Technology Fund

About

Autism Impact Fund’s bold mission is to revolutionize the status quo for diagnosing, treating, and living with autism through a venture capital model that helps accelerate developing and delivering emerging technologies, translational science, and innovative services to empower individuals to reach their full potential.

INVESTMENT MANDATE

We identify unmet needs across the continuum of autism and related neurodevelopmental disorders and deploy venture capital to invent, develop, and fuel solutions that address those needs.

OUR TEAM

Exerperienced.
Focused.
Multi-dimensional.

OUR PORTFOLIO

Breakthrough Life Sciences & Innovative Data & Tech-Enabled Services

OUR IMPACT

Measurable.
Autism-Specific.
NDD Applicable.